CYCLOSPORINE-A INHIBITS CD40 LIGAND EXPRESSION IN T-LYMPHOCYTES

被引:133
|
作者
FULEIHAN, R
RAMESH, N
HORNER, A
AHERN, D
BELSHAW, PJ
ALBERG, DG
STAMENKOVIC, I
HARMON, W
GEHA, RS
机构
[1] HARVARD UNIV,SCH MED,CHILDRENS HOSP,DIV NEPHROL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
来源
JOURNAL OF CLINICAL INVESTIGATION | 1994年 / 93卷 / 03期
关键词
GENE ACTIVATION; CALCINEURIN; TRANSCRIPTION FACTORS; TRANSPLANTATION; IMMUNOSUPPRESSANTS;
D O I
10.1172/JCI117089
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The ligand for CD40 is expressed on activated T lymphocytes and delivers contact-dependent activation signals to B lymphocytes. The mechanisms regulating CD40 ligand gene expression are largely unknown. Optimal expression of CD40 ligand required activation of protein kinase C and a rise in intracellular calcium concentration. CD40 ligand expression was inhibited by pretreatment of T cells with cyclosporin A. Cyclosporin A analogues inhibited CD40 ligand expression with a potency mirroring the ability of each compound to inhibit calcineurin activity, indicating that calcineurin plays a key role in CD40 ligand gene expression. Cyclosporin A inhibited IL-4-driven CD40 ligand-dependent IgE isotype switching in PBMC but did not inhibit IgE synthesis induced by CD40 mAb plus IL-4. PBMC derived from transplant patients receiving cyclosporin A failed to express CD40 ligand upon stimulation. These results suggest that patients receiving cyclosporin A may be deficient in CD40 ligand-dependent T cell help.
引用
收藏
页码:1315 / 1320
页数:6
相关论文
共 50 条
  • [31] Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils
    Hirano, Toru
    Arimitsu, Junsuke
    Higa, Shinji
    Naka, Tetsuji
    Ogata, Atsushi
    Shima, Yoshihito
    Fujimoto, Minoru
    Yamadori, Tomoki
    Ohkawara, Tomoharu
    Kuwabara, Yusuke
    Kawai, Mari
    Kawase, Ichiro
    Tanaka, Toshio
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 140 (02) : 150 - 156
  • [32] CD40 LIGAND CD40 DEFICIENCY
    CASTIGLI, E
    FULEIHAN, R
    RAMESH, N
    TSITSIKOV, E
    TSYTSYKOVA, A
    GEHA, RS
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 37 - 39
  • [33] DEXAMETHASONE (DEX) AND CYCLOSPORINE-A (CSA) INHIBIT CD4 REEXPRESSION ON LECTIN ACTIVATED T-LYMPHOCYTES
    HACZKU, A
    KAY, AB
    CORRIGAN, CJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (02): : 187 - 187
  • [34] TRANSIENT EXPRESSION OF A 32-KD LIGAND FOR THE CD40 ANTIGEN ON ACTIVATED HUMAN LYMPHOCYTES-T
    GALIZZI, JP
    HERMANN, P
    DESAINTVIS, B
    FOSSIEZ, F
    VANBERVLIET, B
    BLANCHARD, D
    BRIERE, F
    BANCHEREAU, J
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 90 - 90
  • [35] Constitutive expression of CD40 ligand (CD40L) on T lymphocytes of patients with chronic graft versus host disease.
    Bolotin, E
    Masinsin, B
    Burotto, F
    Smogorzewska, EM
    Brooks, J
    Parkman, R
    Weinberg, K
    BLOOD, 1997, 90 (10) : 1675 - 1675
  • [36] Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis
    Huang, WX
    Huang, P
    Hillert, J
    MULTIPLE SCLEROSIS, 2000, 6 (02): : 61 - 65
  • [37] Platelet expression of CD40 and CD40 ligand during persistent atrial fibrillation
    Hammwöhner, M
    Ittenson, A
    Dierkes, J
    Klein, HU
    Goette, A
    CIRCULATION, 2004, 110 (17) : 742 - 742
  • [38] Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection
    Mengel, M
    Mueller, I
    Behrend, M
    von Wasielewski, R
    Radermacher, J
    Schwarz, A
    Haller, H
    Kreipe, H
    TRANSPLANT INTERNATIONAL, 2004, 17 (06) : 293 - 300
  • [39] Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes
    Hsu, YM
    Lucci, J
    Su, LH
    Ehrenfels, B
    Garber, E
    Thomas, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 911 - 915
  • [40] CYCLOSPORINE-A IMPROVES SEVERE ATOPIC-DERMATITIS IN ADULTS AND REDUCES ACTIVATED CD4(+) T-LYMPHOCYTES
    GARNIERLYONNET, S
    THIVOLET, J
    VANDONGEN, M
    VIAC, J
    FRAPPAZ, A
    EUROPEAN JOURNAL OF DERMATOLOGY, 1995, 5 (06) : 481 - 485